Skip to main content

ORIGINAL RESEARCH article

Front. Trop. Dis.
Sec. Antimicrobial Resistance
Volume 5 - 2024 | doi: 10.3389/fitd.2024.1497220
This article is part of the Research Topic Antimicrobial Resistance Response Perspectives in Africa View all articles

Assessment of the Implementation of Antimicrobial Stewardship Programs in Selected Healthcare Facilities in Kenya

Provisionally accepted
Nkatha Gitonga Nkatha Gitonga 1*Oscar Agoro Oscar Agoro 2Mitchel Okumu Mitchel Okumu 3Ndinda Kusu Ndinda Kusu 1Joseph Mukoko Joseph Mukoko 1Helen Wangai Helen Wangai 1Tamara Hafner Tamara Hafner 4Mohan P Joshi Mohan P Joshi 4
  • 1 Management Sciences of Health, United States Agency for International Development (USAID) Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Nairobi, Kenya
  • 2 Department of Health, Nyeri County Government, Nyeri, Kenya
  • 3 Department of Health, Kisumu County Government, Kisumu, Kenya
  • 4 USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, United States

The final, formatted version of the article will be published soon.

    Background: Antimicrobial resistance (AMR) is a growing concern globally and is notably prevalent in Kenya. The World Health Organization's (WHO) Global Action Plan (GAP) and the Kenya National Action Plan (NAP) on AMR emphasize the need for effective antimicrobial stewardship (AMS) programs to combat AMR. The USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program has supported AMS implementation in 20 healthcare facilities (HCFs) in Nyeri, Kisumu, Murang'a, and Kilifi counties since 2019, focussing on developing and operationalizing AMS programs based on national, WHO, and Centres for Disease Control and Prevention (CDC)guidelines. However, there is paucity of information on how the AMS programs have been implemented in Nyeri and Kisumu Counties. This study evaluates the progress in AMS program implementation in Nyeri and Kisumu Counties between 2019 and 2023.Methods: Baseline and follow up assessments were conducted using a 33 item AMS questionnaire adapted from the CDC's Core Elements of Hospital Antibiotic Stewardship Programs (CEHASP) and WHO guidelines. The assessment evaluated 13 thematic areas.Results: AMS implementation showed significant improvements, with Nyeri county increasing from 12% to 76% and Kisumu from 17% to 78%. Several elements achieved 100% implementation in both counties, including core governance structures, accountability, and medical expertise. Education programs reached 88% implementation in Nyeri and 100% in Kisumu. Leadership support improved from 0% to 60% in Nyeri and from 0% to 54% in Kisumu. However, tracking antimicrobial use (AMU) and resistance (AMR) through process measures remained the lowest implemented element (33% in Nyeri, 19% in Kisumu). Other challenges included limited microbiology services affecting antibiogram production, inadequate monitoring of adherence to treatment guidelines (0-7% implementation), and suboptimal implementation of policies and guidelines (48-58%).Conclusions: These findings suggest that ASP implementation in Kenyan healthcare facilities can be successful in resource-limited settings, as evidenced by the improvements in core governance structures, accountability, and medical expertise. However, critical gaps remain in tracking antimicrobial use and resistance and monitoring treatment guideline adherence. To strengthen ASPs, we recommend establishing standardized national protocols for tracking and monitoring, developing regional laboratory networks to improve microbiology services access, and implementing electronic health records systems.

    Keywords: Antimicrobial stewardship (AMS), Antimicrobial resistance (AMR), resource-limited settings, antimicrobial stewardship program (ASP) assessment, Healthcare facilities

    Received: 16 Sep 2024; Accepted: 20 Dec 2024.

    Copyright: © 2024 Gitonga, Agoro, Okumu, Kusu, Mukoko, Wangai, Hafner and Joshi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Nkatha Gitonga, Management Sciences of Health, United States Agency for International Development (USAID) Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Nairobi, Kenya

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.